Biobusiness Development Grants Awarded

Biobusiness grants help develop Minnesota businesses and infrastructure to deliver regenerative medicine products and services. Learn more about how to apply for a biobusiness grant by reading our frequently asked questions

 

View bio business grants awarded by year.
Zachary Resch, PhD
The Mayo Clinic CRM Biotrust has the role of escalating promising cellular and acellular biologics from bench to clinical-grade products, through…
2018-2019
James R. Dutton, PhD
Funding to equip laboratory space at the UMN Stem Cell Institute to provide a shared-space Innovation and Prototype Facility to support start-up…
2018-2019
Alicia Wallis, PhD
Equipment for CD34 cell isolation and selection in our planned cGMP operation for regenerative medicine.
2018-2019
Satsuki Yamada, MD, PhD
This proposal aims to establish the state‐of‐the‐art ultrasound platform armed with photoacoustic technology specialized for regenerative therapies…
2018-2019
James R. Thompson, PhD
The goal of this project is to prove that commercial production of regenerative proteins can be made consistently and with a significant cost…
2018-2019
James Thompson, PhD
After completing "proof of concept" experiments that produced human proteins in tobacco plants and acquiring a new lab facility, we seek to upscale…
2017-2018
John Schorgl, BA
Peytant Solutions is developing a human amnion tissue cover scaffold, called the AmnioStent™, for the treatment of malignant airway strictures. …
2017-2018
Walter C. Low, PhD
The goal of this project is to produce authentic human dopamine neurons that can be used for cell transplantation therapy for patients with…
2017-2018
Saad Kenderian, MD
The goal of this project is to establish the infrastructure for the development of chimeric antigen receptor T (CART) cell therapy at the Mayo…
2017-2018
Yasuhiro Ikeda, DVM, PhD
Our product is MC-iLETS01, Mayo Center for Regenerative Medicine-original iPSC-derived islet cell product in a retrievable encapsulation device,…
2017-2018
Leah Hogdal, PhD
We intend to use a new form of genetic correction we’ve developed to correct mitochondrial gene mutations that cause a progressive form of…
2017-2018
James Dutton, PhD
  Age-related macular degeneration (AMD) is a devastating disease of aging and the leading cause of blindness in people aged 50 and older in…
2017-2018